Panarum

[Not Yet Scheduled]
We successfully create and market Proteoral®, our proprietary technology is the only universal oral delivery system of proteins to the circulation system totally effective in therapies with oral proteins.
Proteoral® benefits the lives of patients who receive these therapies.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Argentina
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Proteoral
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
CEO
PANARUM